NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Sees Large Growth in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 14,100 shares, a growth of 1,075.0% from the March 31st total of 1,200 shares. Based on an average daily trading volume, of 21,900 shares, the days-to-cover ratio is presently 0.6 days.

NRx Pharmaceuticals Stock Performance

Shares of NRx Pharmaceuticals stock remained flat at $0.15 during trading on Thursday. The stock had a trading volume of 27,623 shares, compared to its average volume of 24,644. NRx Pharmaceuticals has a 52 week low of $0.05 and a 52 week high of $0.39. The stock has a fifty day moving average price of $0.17 and a two-hundred day moving average price of $0.13.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics based on N-methyl-D-aspartate platform for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated investigational breakthrough therapy for suicidal treatment-resistant bipolar depression and chronic pain; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of acute suicidality in depression.